| Bioactivity | Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disordersTarget：Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes. | ||||||||||||
| Name | Suloctidil | ||||||||||||
| CAS | 54767-75-8 | ||||||||||||
| Formula | C20H35NOS | ||||||||||||
| Molar Mass | 337.56 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Chatelain P, et al. Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes. Biochem Pharmacol. 1979 Dec 15;28(24):3677-3680. |